LXRX FY 2016 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$83M-35.9% YoY

Gross Profit

-$81M-96.8% margin

Operating Income

-$137M-164.6% margin

Net Income

-$141M-169.7% margin

EPS (Diluted)

$-1.36

Cash Flow

Operating Cash Flow

-$176M

Free Cash Flow

-$176M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$476M

Total Liabilities

$318M

Stockholders' Equity

$157M

Cash & Equivalents

$347M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83M	$130M	-35.9%
Gross Profit	-$81M	$35M	-331.5%
Operating Income	-$137M	$1M	-9443.0%
Net Income	-$141M	-$5M	-2920.7%